Effects of postoperative pain management on immune function after laparoscopic resection of colorectal cancer: A randomized study

So Yeon Kim, Nam Kyu Kim, Seung Hyuk Baik, Byung Soh Min, Hyuk Hur, Jinae Lee, Hyun Young Noh, Jong Ho Lee, Bon Neyo Koo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

There has been a rising interest in the possible association between perioperative opioid use and postoperative outcomes in cancer patients. Continuous surgical wound infiltration with local anesthetics is a nonopioid analgesic technique that can be used as a postoperative pain management alternative to opioid-based intravenous patient-controlled analgesia (IV PCA). The aim of this study was to compare the effects of an opioid-based analgesic regimen versus a local anesthetic wound infiltration-based analgesic regimen on immune modulation and shortterm cancer recurrence or metastasis in patients undergoing laparoscopic resection of colorectal cancer. Sixty patients undergoing laparoscopic resection of colorectal cancer were randomly assigned to either the opioid group or the ON-Q group. For postoperative analgesia during the first 48 hours, the opioid group (n=30) received fentanyl via IV PCA, whereas the ON-Q group (n=30) received continuous wound infiltration of 0.5% ropivacaine with an ON-Q pump and tramadol via IV PCA. Pethidine for the opioid group and ketorolac or propacetamol for the ON-Q group were used as rescue analgesics. Anesthesia was induced and maintained with propofol and remifentanil. The primary outcome was postoperative immune function assessed by natural killer cell cytotoxicity (NKCC) and interleukin-2. Secondary outcomes were postoperative complications, cancer recurrence, or metastasis within 1 year after surgery, and postoperative inflammatory responses measured by white blood cell count, neutrophil percentage, and C-reactive protein. Immune function and inflammatory responses were measured before surgery and 24 and 48 hours after surgery. Fifty-nine patients completed the study. In the circumstance of similar pain control efficacy between the opioid group and the ON-Q group, postoperative NKCC and interleukin-2 levels did not differ between the 2 groups. The incidence of postoperative complications and recurrence or metastasis within 1 year after surgery was comparable between the groups. Postoperative inflammatory responses were also similar between the groups. When compared with ropivacaine wound infiltration-based analgesia, fentanyl-based analgesia did not further decrease NKCC or affect short-term cancer recurrence or metastasis. Thus, a fentanyl-based analgesic regimen and a ropivacaine wound infiltration-based analgesic regimen can both be used for postoperative pain management in laparoscopic resection of colorectal cancer.

Original languageEnglish
Article numbere3602
JournalMedicine (United States)
Volume95
Issue number19
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Pain Management
Postoperative Pain
Opioid Analgesics
Colorectal Neoplasms
Patient-Controlled Analgesia
Analgesics
Fentanyl
Natural Killer Cells
Analgesia
Neoplasm Metastasis
Recurrence
Wounds and Injuries
Local Anesthetics
Interleukin-2
Neoplasms
Non-Narcotic Analgesics
Ketorolac
Tramadol
Meperidine
Propofol

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Kim, So Yeon ; Kim, Nam Kyu ; Baik, Seung Hyuk ; Min, Byung Soh ; Hur, Hyuk ; Lee, Jinae ; Noh, Hyun Young ; Lee, Jong Ho ; Koo, Bon Neyo. / Effects of postoperative pain management on immune function after laparoscopic resection of colorectal cancer : A randomized study. In: Medicine (United States). 2016 ; Vol. 95, No. 19.
@article{a0c49b34ab554101a23b88ce48070389,
title = "Effects of postoperative pain management on immune function after laparoscopic resection of colorectal cancer: A randomized study",
abstract = "There has been a rising interest in the possible association between perioperative opioid use and postoperative outcomes in cancer patients. Continuous surgical wound infiltration with local anesthetics is a nonopioid analgesic technique that can be used as a postoperative pain management alternative to opioid-based intravenous patient-controlled analgesia (IV PCA). The aim of this study was to compare the effects of an opioid-based analgesic regimen versus a local anesthetic wound infiltration-based analgesic regimen on immune modulation and shortterm cancer recurrence or metastasis in patients undergoing laparoscopic resection of colorectal cancer. Sixty patients undergoing laparoscopic resection of colorectal cancer were randomly assigned to either the opioid group or the ON-Q group. For postoperative analgesia during the first 48 hours, the opioid group (n=30) received fentanyl via IV PCA, whereas the ON-Q group (n=30) received continuous wound infiltration of 0.5{\%} ropivacaine with an ON-Q pump and tramadol via IV PCA. Pethidine for the opioid group and ketorolac or propacetamol for the ON-Q group were used as rescue analgesics. Anesthesia was induced and maintained with propofol and remifentanil. The primary outcome was postoperative immune function assessed by natural killer cell cytotoxicity (NKCC) and interleukin-2. Secondary outcomes were postoperative complications, cancer recurrence, or metastasis within 1 year after surgery, and postoperative inflammatory responses measured by white blood cell count, neutrophil percentage, and C-reactive protein. Immune function and inflammatory responses were measured before surgery and 24 and 48 hours after surgery. Fifty-nine patients completed the study. In the circumstance of similar pain control efficacy between the opioid group and the ON-Q group, postoperative NKCC and interleukin-2 levels did not differ between the 2 groups. The incidence of postoperative complications and recurrence or metastasis within 1 year after surgery was comparable between the groups. Postoperative inflammatory responses were also similar between the groups. When compared with ropivacaine wound infiltration-based analgesia, fentanyl-based analgesia did not further decrease NKCC or affect short-term cancer recurrence or metastasis. Thus, a fentanyl-based analgesic regimen and a ropivacaine wound infiltration-based analgesic regimen can both be used for postoperative pain management in laparoscopic resection of colorectal cancer.",
author = "Kim, {So Yeon} and Kim, {Nam Kyu} and Baik, {Seung Hyuk} and Min, {Byung Soh} and Hyuk Hur and Jinae Lee and Noh, {Hyun Young} and Lee, {Jong Ho} and Koo, {Bon Neyo}",
year = "2016",
month = "1",
day = "1",
doi = "10.1097/MD.0000000000003602",
language = "English",
volume = "95",
journal = "Medicine (United States)",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "19",

}

Effects of postoperative pain management on immune function after laparoscopic resection of colorectal cancer : A randomized study. / Kim, So Yeon; Kim, Nam Kyu; Baik, Seung Hyuk; Min, Byung Soh; Hur, Hyuk; Lee, Jinae; Noh, Hyun Young; Lee, Jong Ho; Koo, Bon Neyo.

In: Medicine (United States), Vol. 95, No. 19, e3602, 01.01.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of postoperative pain management on immune function after laparoscopic resection of colorectal cancer

T2 - A randomized study

AU - Kim, So Yeon

AU - Kim, Nam Kyu

AU - Baik, Seung Hyuk

AU - Min, Byung Soh

AU - Hur, Hyuk

AU - Lee, Jinae

AU - Noh, Hyun Young

AU - Lee, Jong Ho

AU - Koo, Bon Neyo

PY - 2016/1/1

Y1 - 2016/1/1

N2 - There has been a rising interest in the possible association between perioperative opioid use and postoperative outcomes in cancer patients. Continuous surgical wound infiltration with local anesthetics is a nonopioid analgesic technique that can be used as a postoperative pain management alternative to opioid-based intravenous patient-controlled analgesia (IV PCA). The aim of this study was to compare the effects of an opioid-based analgesic regimen versus a local anesthetic wound infiltration-based analgesic regimen on immune modulation and shortterm cancer recurrence or metastasis in patients undergoing laparoscopic resection of colorectal cancer. Sixty patients undergoing laparoscopic resection of colorectal cancer were randomly assigned to either the opioid group or the ON-Q group. For postoperative analgesia during the first 48 hours, the opioid group (n=30) received fentanyl via IV PCA, whereas the ON-Q group (n=30) received continuous wound infiltration of 0.5% ropivacaine with an ON-Q pump and tramadol via IV PCA. Pethidine for the opioid group and ketorolac or propacetamol for the ON-Q group were used as rescue analgesics. Anesthesia was induced and maintained with propofol and remifentanil. The primary outcome was postoperative immune function assessed by natural killer cell cytotoxicity (NKCC) and interleukin-2. Secondary outcomes were postoperative complications, cancer recurrence, or metastasis within 1 year after surgery, and postoperative inflammatory responses measured by white blood cell count, neutrophil percentage, and C-reactive protein. Immune function and inflammatory responses were measured before surgery and 24 and 48 hours after surgery. Fifty-nine patients completed the study. In the circumstance of similar pain control efficacy between the opioid group and the ON-Q group, postoperative NKCC and interleukin-2 levels did not differ between the 2 groups. The incidence of postoperative complications and recurrence or metastasis within 1 year after surgery was comparable between the groups. Postoperative inflammatory responses were also similar between the groups. When compared with ropivacaine wound infiltration-based analgesia, fentanyl-based analgesia did not further decrease NKCC or affect short-term cancer recurrence or metastasis. Thus, a fentanyl-based analgesic regimen and a ropivacaine wound infiltration-based analgesic regimen can both be used for postoperative pain management in laparoscopic resection of colorectal cancer.

AB - There has been a rising interest in the possible association between perioperative opioid use and postoperative outcomes in cancer patients. Continuous surgical wound infiltration with local anesthetics is a nonopioid analgesic technique that can be used as a postoperative pain management alternative to opioid-based intravenous patient-controlled analgesia (IV PCA). The aim of this study was to compare the effects of an opioid-based analgesic regimen versus a local anesthetic wound infiltration-based analgesic regimen on immune modulation and shortterm cancer recurrence or metastasis in patients undergoing laparoscopic resection of colorectal cancer. Sixty patients undergoing laparoscopic resection of colorectal cancer were randomly assigned to either the opioid group or the ON-Q group. For postoperative analgesia during the first 48 hours, the opioid group (n=30) received fentanyl via IV PCA, whereas the ON-Q group (n=30) received continuous wound infiltration of 0.5% ropivacaine with an ON-Q pump and tramadol via IV PCA. Pethidine for the opioid group and ketorolac or propacetamol for the ON-Q group were used as rescue analgesics. Anesthesia was induced and maintained with propofol and remifentanil. The primary outcome was postoperative immune function assessed by natural killer cell cytotoxicity (NKCC) and interleukin-2. Secondary outcomes were postoperative complications, cancer recurrence, or metastasis within 1 year after surgery, and postoperative inflammatory responses measured by white blood cell count, neutrophil percentage, and C-reactive protein. Immune function and inflammatory responses were measured before surgery and 24 and 48 hours after surgery. Fifty-nine patients completed the study. In the circumstance of similar pain control efficacy between the opioid group and the ON-Q group, postoperative NKCC and interleukin-2 levels did not differ between the 2 groups. The incidence of postoperative complications and recurrence or metastasis within 1 year after surgery was comparable between the groups. Postoperative inflammatory responses were also similar between the groups. When compared with ropivacaine wound infiltration-based analgesia, fentanyl-based analgesia did not further decrease NKCC or affect short-term cancer recurrence or metastasis. Thus, a fentanyl-based analgesic regimen and a ropivacaine wound infiltration-based analgesic regimen can both be used for postoperative pain management in laparoscopic resection of colorectal cancer.

UR - http://www.scopus.com/inward/record.url?scp=84970028860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84970028860&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000003602

DO - 10.1097/MD.0000000000003602

M3 - Article

C2 - 27175664

AN - SCOPUS:84970028860

VL - 95

JO - Medicine (United States)

JF - Medicine (United States)

SN - 0025-7974

IS - 19

M1 - e3602

ER -